Pancreatic exocrine and endocrine function after subtotal pancreatectomy for nesidioblastosis.
Pancreatic exocrine and endocrine function was assessed in seven patients 1 to 2 years after 95% pancreatectomy (group A) and three patients 9 to 11 years after 75% pancreatectomy (group B). In all cases surgery was undertaken for the treatment of hyperinsulinism and the histologic diagnosis was nesidioblastosis. The activities of pancreatic enzymes and bicarbonate concentrations were generally normal in group B, but were reduced in approximately half the children in group A. One child in group A had significant exocrine failure and poor weight gain. Blood glucose levels and fasting insulin levels were normal during a standard glucose tolerance test in all of the group B patients. One had a low fasting blood glucose level. In the group A patients three had low fasting glucose levels and one a frankly diabetic glucose tolerance test. C peptide and insulin levels were comparable but inappropriate insulin levels were noted in one patient, suggesting that the control of glucose-stimulated insulin release may remain abnormal. The results suggest that pancreatic function is not seriously impaired in the majority of patients 1 to 2 years after 95% pancreatectomy and that it is comparable to that noted in 75% pancreatectomy patients followed over a longer period of time.
D000681:Amylases / Q000378:metabolism; D001639:Bicarbonates / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000378:metabolism; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000503:physiopathology*; D008297:Male; D010179:Pancreas / Q000201:enzymology*; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000601:surgery*; D011184:Postoperative Period; D014357:Trypsin / Q000378:metabolism
D001639:Bicarbonates; D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D000681:Amylases; D014357:Trypsin